4Cable Tv Internatio

PINK:CATV USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.15 Million
Market Cap Rank
#51019 Global
#15735 in USA
Share Price
$0.00
Change (1 day)
-33.33%
52-Week Range
$0.00 - $0.00
All Time High
$0.04
About

Opus Holdings, Inc. operates as a business incubator. The company acquires, develops, transitions private companies into public markets. It provides guidance, financial resources, and market expertise to businesses. Opus Holdings, Inc. was formerly known as 4Cable TV International, Inc. and changed its name to Opus Holdings, Inc. in March 2025. The company was incorporated in 2007 and is based in… Read more

4Cable Tv Internatio (CATV) - Net Assets

Latest net assets as of March 2025: $11.67 Million USD

Based on the latest financial reports, 4Cable Tv Internatio (CATV) has net assets worth $11.67 Million USD as of March 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.59 Million) and total liabilities ($4.92 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $11.67 Million
% of Total Assets 70.36%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 295.87

4Cable Tv Internatio - Net Assets Trend (2011–2024)

This chart illustrates how 4Cable Tv Internatio's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for 4Cable Tv Internatio (2011–2024)

The table below shows the annual net assets of 4Cable Tv Internatio from 2011 to 2024.

Year Net Assets Change
2024-12-31 $11.36 Million +15.18%
2023-12-31 $9.86 Million +1053.16%
2018-12-31 $-1.03 Million -8.10%
2017-12-31 $-957.11K -6.30%
2016-12-31 $-900.42K -116.55%
2014-12-31 $-415.81K -576.56%
2013-12-31 $87.25K +229.56%
2012-12-31 $-67.34K -38.21%
2011-12-31 $-48.73K --

Equity Component Analysis

This analysis shows how different components contribute to 4Cable Tv Internatio's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 319331700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $186.39K 1.68%
Other Components $14.10 Million 127.15%
Total Equity $11.09 Million 100.00%

4Cable Tv Internatio Competitors by Market Cap

The table below lists competitors of 4Cable Tv Internatio ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in 4Cable Tv Internatio's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 9,862,406 to 11,089,332, a change of 1,226,926 (12.4%).
  • Net loss of 23,782 reduced equity.
  • Other comprehensive income increased equity by 36,688.
  • Other factors increased equity by 1,214,020.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-23.78K -0.21%
Other Comprehensive Income $36.69K +0.33%
Other Changes $1.21 Million +10.95%
Total Change $- 12.44%

Book Value vs Market Value Analysis

This analysis compares 4Cable Tv Internatio's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.07x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-12-31 $0.00 $0.00 x
2008-12-31 $0.00 $0.00 x
2009-12-31 $0.00 $0.00 x
2010-12-31 $0.00 $0.00 x
2011-12-31 $0.00 $0.00 x
2012-12-31 $0.00 $0.00 x
2013-12-31 $0.00 $0.00 x
2014-12-31 $-0.01 $0.00 x
2016-12-31 $0.00 $0.00 x
2017-12-31 $0.00 $0.00 x
2018-12-31 $0.00 $0.00 x
2023-12-31 $0.00 $0.00 x
2024-12-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently 4Cable Tv Internatio utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -0.21%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -3.69%
  • • Asset Turnover: 0.04x
  • • Equity Multiplier: 1.58x
  • Recent ROE (-0.21%) is above the historical average (-11.46%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 -10.26% 0.00% 0.00x 1.00x $-7.90K
2008 0.00% 0.00% 0.00x 0.00x $-44.40K
2009 0.00% 0.00% 0.00x 0.00x $-8.40K
2010 0.00% 0.00% 0.00x 0.00x $-9.73K
2011 0.00% -5.07% 85.37x 0.00x $-15.26K
2012 0.00% -2.95% 916.19x 0.00x $-11.88K
2013 -147.36% -12.51% 1.43x 8.24x $-137.30K
2014 0.00% -104.09% 1.42x 0.00x $-1.03 Million
2016 0.00% 0.00% 0.00x 0.00x $-171.76K
2017 0.00% 0.00% 0.00x 0.00x $5.91K
2018 0.00% 0.00% 0.00x 0.00x $18.54K
2023 8.79% 190.80% 0.03x 1.55x $-119.08K
2024 -0.21% -3.69% 0.04x 1.58x $-1.13 Million

Industry Comparison

This section compares 4Cable Tv Internatio's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
4Cable Tv Internatio (CATV) $11.67 Million -10.26% 0.42x $1.92
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million